Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term second remissions in acute lymphatic leukemia.

B G Leventhal, A S Levine, R G Graw

    Cancer
    |April 11, 1975
    PubMed
    Summary

    Long-term second remissions are possible in patients with ALL (acute lymphoblastic leukemia). Relapsed patients achieving over six months of unmaintained remission may achieve cure with initial induction drugs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats.

    American journal of physiology. Regulatory, integrative and comparative physiology·2006
    Same author

    Centrally administered orexin A increases motivation for sweet pellets in rats.

    Psychopharmacology·2005
    Same author

    Behavioral and neurochemical mechanisms of the action of mild stress in the enhancement of feeding.

    Behavioral neuroscience·2004
    Same author

    Naloxone's effect on meal microstructure of sucrose and cornstarch diets.

    American journal of physiology. Regulatory, integrative and comparative physiology·2001
    Same author

    The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.

    Brain research·2001
    Same author

    Role of alpha-MSH in the regulation of consummatory behavior: immunohistochemical evidence.

    American journal of physiology. Regulatory, integrative and comparative physiology·2001

    Area of Science:

    • Hematology
    • Oncology
    • Internal Medicine

    Background:

    • Relapse in acute lymphoblastic leukemia (ALL) remains a significant challenge.
    • Understanding patterns of relapse and potential for second remissions is crucial for improving patient outcomes.

    Purpose of the Study:

    • To investigate the occurrence and characteristics of long-term second remissions in patients with ALL.
    • To identify predictors of successful re-induction therapy after relapse.

    Main Methods:

    • Retrospective analysis of 66 patients diagnosed with ALL.
    • Detailed review of remission durations, relapse patterns (extramedullary vs. marrow), and pre-relapse laboratory findings (marrow lymphocytosis, eosinophilia).
    • Evaluation of treatment response to second-line therapies.

    Related Experiment Videos

    Main Results:

    • Five out of 66 patients achieved long-term second remissions.
    • Relapses were extramedullary in 2/5 patients.
    • Preceding relapse, 4/5 patients showed progressive marrow lymphocytosis, and 1/5 showed marrow eosinophilia.
    • All patients with second remissions had maintained remission for at least 6 months prior to relapse.
    • Second remissions were achieved using similar initial induction drugs.

    Conclusions:

    • Long-term second remissions are achievable in a subset of ALL patients.
    • Patients relapsing after a prolonged unmaintained remission (≥6 months) represent a potential group for curative therapy.
    • Re-treatment with initial induction regimens should be considered for these patients with the aim of achieving cure.